United BioSource, LLC
14
2
2
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
14.3%
2 terminated/withdrawn out of 14 trials
80.0%
-6.5% vs industry average
0%
0 trials in Phase 3/4
25%
2 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
A Non-interventional Cohort Safety Study of Patients With hATTR-PN
Role: collaborator
A Prospective Observational Registry of Patients Treated With LUPKYNIS® (Voclosporin) in the US
Role: collaborator
Phase 2 Study of S-1 in Advanced or Metastatic Pancreatic Cancer
Role: collaborator
Phase 2 Study of S-1 in Combination With Cisplatin as 1st Line Therapy in Advanced Non-Small Cell Lung Cancer
Role: collaborator
Phase 2 Study of S-1 as 2nd Line Therapy in Advanced Non-Small Cell Lung Cancer
Role: collaborator
An Observational Registry to Evaluate the Incidence of and Risk Factors for Vascular Occlusive Events Associated With ICLUSIG®
Role: collaborator
A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta
Role: collaborator
Phase 2B Micronized DHACM vs. Saline in the Treatment of Knee Osteoarthritis
Role: collaborator
An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)
Role: collaborator
AveXis Managed Access Program Cohort for Access to AVXS-101
Role: lead
JC-Virus (JCV) Antibody Program
Role: collaborator
Developing a COPD Case Finding Methodology for Primary Care
Role: collaborator
A Study of LY2189265 Compared to Sitagliptin in Participants With Type 2 Diabetes Mellitus on Metformin
Role: collaborator
Effectiveness of Beclomethasone Dipropionate Nasal Aerosol for Perennial Allergic Rhinitis
Role: collaborator
All 14 trials loaded